Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06404177

Enantyum® IV Versus Piroxen® IM in Emergency Pain Management

Dexketoprofen ® IV Versus Piroxicam® IM in Emergency Pain Management

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Riadh Boukef · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

For pain of traumatic origin, the RICE protocol (Rest, Ice, Compression, Elevation) is the main therapeutic measure during the first 4 to 5 days post-trauma. However, there is currently insufficient evidence that this protocol is effective \[4\]. In the emergency department, paracetamol, NSAIDs or a combination of several molecules are generally prescribed. Patients even use these drugs without a prescription. The aim of this study is to Compare the effect of dexketoprofen® IV versus piroxen® IM in the treatment of pain in emergency departments.

Detailed description

This was a prospective, randomized, double-blind, controlled study conducted at the Sahloul emergency department, Sousse. Study duration: 3 months. Inclusion criteria: Patients over 18 years of age requiring analgesia for acute pain of traumatic origin and who signed a written consent form were included in this study. Exclusion criteria: Patients who meet the following conditions: * refusal, incapacity, difficulties with consent or communication * Patients with chronic pain. * Any known allergy or secondary reaction to piroxen or dexketoprofen trometamol. * Pregnant women. * Cirrhosis of the liver. Methodology: 1. Dexketoprofen group Patient receives an intravenous injection of Dexketoprofen + IM placebo + follow-up sheet + appointment card. 2. Piroxican group. Patients receive one intramuscular Piroxen injection + IV SSI infusion + follow-up sheet + appointment card. For each patient included, VAS, blood pressure, heart rate, respiratory rate and Sa02 are taken on admission and discharge from the emergency department, and at the second telephone visit after 07 days. At the 7th day visit (by telephone), patients were asked to answer satisfaction questions and complete the EQ50 quality of life questionnaire.

Conditions

Interventions

TypeNameDescription
DRUGDexketoprofenAn intravenous perfusion of eunantyum with an intramuscular isotonic saline
DRUGPiroxicamintramuscular injection of piroxicam with a perfusion of isotonic saline intravenous

Timeline

Start date
2023-07-15
Primary completion
2024-08-01
Completion
2024-08-30
First posted
2024-05-08
Last updated
2024-05-08

Locations

1 site across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT06404177. Inclusion in this directory is not an endorsement.